title: Phase I study of non-replicating autologous tumor cell injections using cells prepared with or without GM-CSF gene transduction in patients with metastatic renal cell carcinoma.
authors.affiliation: Somatix Therapy Corporation, Alameda, CA 94501, USA.
authors.forename: A J
authors.initials: AJ
authors.lastname: Berns
authors.forename: S
authors.initials: S
authors.lastname: Clift
authors.forename: L K
authors.initials: LK
authors.lastname: Cohen
authors.forename: R C
authors.initials: RC
authors.lastname: Donehower
authors.forename: G
authors.initials: G
authors.lastname: Dranoff
authors.forename: K M
authors.initials: KM
authors.lastname: Hauda
authors.forename: E M
authors.initials: EM
authors.lastname: Jaffee
authors.forename: A J
authors.initials: AJ
authors.lastname: Lazenby
authors.forename: H I
authors.initials: HI
authors.lastname: Levitsky
authors.forename: F F
authors.initials: FF
authors.lastname: Marshall
mesh_terms: D000818:Animals; D002292:Carcinoma, Renal Cell / Q000473:pathology / Q000556:secondary* / Q000628:therapy*; D017690:Cell Transplantation; D002985:Clinical Protocols; D017321:Clinical Trials, Phase I as Topic; D015316:Genetic Therapy; D016178:Granulocyte-Macrophage Colony-Stimulating Factor / Q000235:genetics* / Q000494:pharmacology; D006801:Humans; D007167:Immunotherapy; D051379:Mice; D014161:Transduction, Genetic; D014182:Transplantation, Autologous; D014407:Tumor Cells, Cultured
chemical_list: D016178:Granulocyte-Macrophage Colony-Stimulating Factor